Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Nat Commun ; 5: 4028, 2014 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-24905578

RESUMO

Mutations in the acid ß-glucocerebrosidase (GBA1) gene, responsible for the lysosomal storage disorder Gaucher's disease (GD), are the strongest genetic risk factor for Parkinson's disease (PD) known to date. Here we generate induced pluripotent stem cells from subjects with GD and PD harbouring GBA1 mutations, and differentiate them into midbrain dopaminergic neurons followed by enrichment using fluorescence-activated cell sorting. Neurons show a reduction in glucocerebrosidase activity and protein levels, increase in glucosylceramide and α-synuclein levels as well as autophagic and lysosomal defects. Quantitative proteomic profiling reveals an increase of the neuronal calcium-binding protein 2 (NECAB2) in diseased neurons. Mutant neurons show a dysregulation of calcium homeostasis and increased vulnerability to stress responses involving elevation of cytosolic calcium. Importantly, correction of the mutations rescues such pathological phenotypes. These findings provide evidence for a link between GBA1 mutations and complex changes in the autophagic/lysosomal system and intracellular calcium homeostasis, which underlie vulnerability to neurodegeneration.


Assuntos
Autofagia , Cálcio/metabolismo , Glucosilceramidase/genética , Homeostase , Células-Tronco Pluripotentes Induzidas/patologia , Neurônios/patologia , Doença de Parkinson/patologia , Diferenciação Celular , Glicosídeo Hidrolases/metabolismo , Humanos , Células-Tronco Pluripotentes Induzidas/enzimologia , Neurônios/enzimologia , Doença de Parkinson/imunologia , Doença de Parkinson/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...